Kristofer Mussar, PhD, is COO of VectorBuilder and MD of VectorBuilder GmbH, leading global operations and innovation in gene delivery. What if business leaders approached strategy the way scientists ...
F rom blockbuster drugs that garner media attention to smaller innovations that help millions maintain health, the biotech and pharmaceutical industries have an impact on everyone’s life. Meanwhile, ...
Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking ...
Join us for Open Doors — as we approach the start of a new year, what trends will be impacting the biotech industry in 2025? And how can biotech executives, communications and marketing officers get ...
Chinese drug makers are increasingly relying on overseas licensing deals to reach global markets amid growing geopolitical ...
T he biotech and pharmaceutical sectors stand at the brink of innovation and strategic transformation. Market momentum continues to build, with the global biotechnology market valued at around $2 ...
Forbes contributors publish independent expert analyses and insights. Jim Osman is a finance expert with over 30 years of experience. As an investor, my greatest returns have usually come from areas ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
This biotech focuses on biologic therapies for immunological diseases, with lead candidates in nephrology and infectious ...
LILLE & PARIS, France--(BUSINESS WIRE)--4Moving Biotech (4MB), a clinical-stage subsidiary of 4P-Pharma specializing in immuno-inflammation and osteoarthritis, is pleased to announce the appointment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results